Casein‐enhanced uptake and disease‐modifying bioactivity of ingested extracellular vesicles
Journal of Extracellular Vesicles2021Vol. 10(3), pp. e12045–e12045
Citations Over Time
M Aminzadeh, Mario Fournier, Akbarshakh Akhmerov, K. Candis Jones‐Ungerleider, Jackelyn Valle, Eduardo Marbán
Abstract
Extracellular vesicles (EVs) from cardiac stromal cells, developed as therapeutic candidates, improve dystrophic muscle function when administered parenterally, but oral delivery remains untested. We find that casein, the dominant protein in breast milk, enhances the uptake and bioactivity of ingested heart-derived EVs, altering gene expression in blood cells and enhancing muscle function in mdx mice with muscular dystrophy. Thus, EVs, administered orally, are absorbed and exert disease-modifying bioactivity in vivo. Formulating EVs with casein enhances uptake and markedly expands the range of potential therapeutic applications.
Related Papers
- → Exosomes and Microvesicles(2016)34 cited
- → The launch of Journal of Extracellular Vesicles (JEV), the official journal of the International Society for Extracellular Vesicles – about microvesicles, exosomes, ectosomes and other extracellular vesicles(2012)22 cited
- → Extracellular Vesicles in Phylogeny(2023)6 cited
- → Extracellular vesicles (exosomes) and parasitic infections: typical isolation and research technologies. Part 1(2020)2 cited
- → Exosomes/EVs: MSC-NTF DERIVED SMALL EXTRACELLULAR VESICLES DISPLAY SUPERIOUR MACROPHAGE IMMUNOMODULATION COMPARED WITH VESICLES DERIVED FROM NAIVE MSC(2022)